Redeye adjusts its estimates and share its preview of Genovis’ Q4 2023 report due on February 15th.
Scandpower excels through licence sales Higher sick leave in Decommissioning Minor revisions with '2...
Blandad utveckling i Q4, sammantaget stabilt 2023 VO2s intäkter under Q4 uppgick till 99 mkr (156 mk...
Försäljningstrenden verkar ha vänt… Med valutajusterad tillväxt på +10% både y/y och sekventiellt ve...
Redeye leaves a short comment following Alzinova’s announcement of a received approval from regulato...
Solteq reports Q4 on February 15th. Our key points of interest relate to the market and growth outlo...
Kvartalsrapporten visade på både högre hyresintäkter och ett förvaltningsresultat som steg.
Redeye saw a report that came in as expected regarding the results.
Redeye sees a Q4 report coming in slightly short of our expectations and a somewhat softer outlook f...
Redeye comments on EG7’s Q4-results which were weaker than expected, mainly owing to a faster-than-e...
Redeye makes downward estimate revisions on the back of I-Tech’s Q4 figures, as sales were slightly ...
Investors House reported Q4 2023 revenue of EUR 1.8m, the same as our estimate, while adjusted EBIT ...
Well positioned to regain growth from AI and cybersecurity Adj.
Över lag kom rapporten in enligt Analysguidens förväntningar.
ChargePanel AB (publ) meddelade den 21 december att bolaget har beslutat genomföra en nyemission av ...
Higher sales and lower costs behind strong margin expansion We lift '24e EBIT by 12% on lower opex a...
Organiska tillväxten accelererar på nedsidan… Med vissa segment inom byggsektorn fortsatt svaga samt...
Q4 – allt under kontroll Ascelias rapport för det fjärde kvartalet innehöll inga överraskningar.
Q4: Clean EBITDA NOK -2.7m - soft compared to our NOK 0m Customer postponing investment hitting prof...
Investors House reported Q4 revenues of EUR 1.8m, in line with our estimate.